Phase III Trial Confirms Pelvic Radiation as Standard of Care for High-Risk, Early-Stage Endometrial Cancer


Newswise imageIn a new phase III trial report from the National Clinical Trial Network group, NRG Oncology, recurrence-free and overall survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy plus chemotherapy when compared with pelvic radiation therapy.